Dimethyltryptamine molecule:

Image from PubChem

DMT Clinical Trials


Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04711915

Organisation Name: Yale University

Overal Status: Not yet recruiting

Start Date: March 1, 2021

Last Update: January 20, 2021

Lead Sponsor: Yale University

Brief Summary: The goal of this fixed order, open-label, dose-escalation study is to investigate the safety and efficacy of specific doses of dimethyltryptamine (DMT) in humans.

Conditions:
  • Major Depressive Disorder
  • Depression


Total execution time in seconds: 0.19702696800232